nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—ADRB2—chronic obstructive pulmonary disease	0.111	0.291	CbGaD
Desipramine—SLC6A4—chronic obstructive pulmonary disease	0.101	0.264	CbGaD
Desipramine—CYP1A2—chronic obstructive pulmonary disease	0.0918	0.241	CbGaD
Desipramine—HTR2A—chronic obstructive pulmonary disease	0.0775	0.203	CbGaD
Desipramine—SLC22A4—Tiotropium—chronic obstructive pulmonary disease	0.0431	0.091	CbGbCtD
Desipramine—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0344	0.0726	CbGbCtD
Desipramine—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0339	0.0715	CbGbCtD
Desipramine—CHRM5—Tiotropium—chronic obstructive pulmonary disease	0.0312	0.0658	CbGbCtD
Desipramine—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.026	0.055	CbGbCtD
Desipramine—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.026	0.055	CbGbCtD
Desipramine—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0257	0.0542	CbGbCtD
Desipramine—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0257	0.0542	CbGbCtD
Desipramine—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.0243	0.0514	CbGbCtD
Desipramine—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0208	0.0439	CbGbCtD
Desipramine—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0208	0.0439	CbGbCtD
Desipramine—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.0199	0.0421	CbGbCtD
Desipramine—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0173	0.0366	CbGbCtD
Desipramine—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.016	0.0337	CbGbCtD
Desipramine—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0157	0.0332	CbGbCtD
Desipramine—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0117	0.0246	CbGbCtD
Desipramine—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.00924	0.0195	CbGbCtD
Desipramine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.00859	0.0181	CbGbCtD
Desipramine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.00859	0.0181	CbGbCtD
Desipramine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.00674	0.0142	CbGbCtD
Desipramine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.00653	0.0138	CbGbCtD
Desipramine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.00653	0.0138	CbGbCtD
Desipramine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.00582	0.0123	CbGbCtD
Desipramine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00548	0.0116	CbGbCtD
Desipramine—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00415	0.182	CbGeAlD
Desipramine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0037	0.00782	CbGbCtD
Desipramine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00361	0.00762	CbGbCtD
Desipramine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00353	0.00746	CbGbCtD
Desipramine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00315	0.00665	CbGbCtD
Desipramine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00308	0.00651	CbGbCtD
Desipramine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00291	0.00615	CbGbCtD
Desipramine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00185	0.0039	CbGbCtD
Desipramine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00174	0.00368	CbGbCtD
Desipramine—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00151	0.0662	CbGeAlD
Desipramine—SMPD1—respiratory system—chronic obstructive pulmonary disease	0.00115	0.0504	CbGeAlD
Desipramine—SMPD1—connective tissue—chronic obstructive pulmonary disease	0.00101	0.0444	CbGeAlD
Desipramine—CYP2C18—bronchus—chronic obstructive pulmonary disease	0.000769	0.0337	CbGeAlD
Desipramine—SMPD1—lung—chronic obstructive pulmonary disease	0.00061	0.0268	CbGeAlD
Desipramine—SLC22A4—respiratory system—chronic obstructive pulmonary disease	0.000541	0.0237	CbGeAlD
Desipramine—SLC6A3—respiratory system—chronic obstructive pulmonary disease	0.000523	0.023	CbGeAlD
Desipramine—SLC6A4—respiratory system—chronic obstructive pulmonary disease	0.000479	0.021	CbGeAlD
Desipramine—SLC22A4—bronchus—chronic obstructive pulmonary disease	0.000445	0.0195	CbGeAlD
Desipramine—ADRB1—connective tissue—chronic obstructive pulmonary disease	0.000437	0.0192	CbGeAlD
Desipramine—SLC22A3—connective tissue—chronic obstructive pulmonary disease	0.000433	0.019	CbGeAlD
Desipramine—SLC6A2—respiratory system—chronic obstructive pulmonary disease	0.000422	0.0185	CbGeAlD
Desipramine—ADRB1—bronchus—chronic obstructive pulmonary disease	0.000408	0.0179	CbGeAlD
Desipramine—SLC22A4—trachea—chronic obstructive pulmonary disease	0.0004	0.0175	CbGeAlD
Desipramine—SLC22A3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000396	0.0174	CbGeAlD
Desipramine—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000384	0.0169	CbGeAlD
Desipramine—SLC22A5—respiratory system—chronic obstructive pulmonary disease	0.000358	0.0157	CbGeAlD
Desipramine—CHRM1—trachea—chronic obstructive pulmonary disease	0.000353	0.0155	CbGeAlD
Desipramine—CHRM3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000344	0.0151	CbGeAlD
Desipramine—CYP2A6—lung—chronic obstructive pulmonary disease	0.000328	0.0144	CbGeAlD
Desipramine—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000324	0.0142	CbGeAlD
Desipramine—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000311	0.0136	CbGeAlD
Desipramine—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000304	0.0133	CbGeAlD
Desipramine—ORM1—lung—chronic obstructive pulmonary disease	0.000299	0.0131	CbGeAlD
Desipramine—SLC22A5—bronchus—chronic obstructive pulmonary disease	0.000295	0.0129	CbGeAlD
Desipramine—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000292	0.0128	CbGeAlD
Desipramine—SLC22A4—lung—chronic obstructive pulmonary disease	0.000287	0.0126	CbGeAlD
Desipramine—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.000284	0.00391	CcSEcCtD
Desipramine—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000282	0.00389	CcSEcCtD
Desipramine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.00385	CcSEcCtD
Desipramine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000279	0.00384	CcSEcCtD
Desipramine—SLC6A3—lung—chronic obstructive pulmonary disease	0.000278	0.0122	CbGeAlD
Desipramine—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.00377	CcSEcCtD
Desipramine—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.00375	CcSEcCtD
Desipramine—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.00375	CcSEcCtD
Desipramine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00027	0.00372	CcSEcCtD
Desipramine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000268	0.0037	CcSEcCtD
Desipramine—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000267	0.0117	CbGeAlD
Desipramine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000267	0.00367	CcSEcCtD
Desipramine—SLC22A5—trachea—chronic obstructive pulmonary disease	0.000265	0.0116	CbGeAlD
Desipramine—ADRB1—lung—chronic obstructive pulmonary disease	0.000263	0.0116	CbGeAlD
Desipramine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000263	0.00362	CcSEcCtD
Desipramine—SLC22A3—lung—chronic obstructive pulmonary disease	0.000261	0.0115	CbGeAlD
Desipramine—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00026	0.00358	CcSEcCtD
Desipramine—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.000259	0.00356	CcSEcCtD
Desipramine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000259	0.00356	CcSEcCtD
Desipramine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000258	0.00355	CcSEcCtD
Desipramine—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000256	0.0112	CbGeAlD
Desipramine—SLC6A4—lung—chronic obstructive pulmonary disease	0.000254	0.0112	CbGeAlD
Desipramine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000254	0.0035	CcSEcCtD
Desipramine—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000254	0.0111	CbGeAlD
Desipramine—CHRM1—lung—chronic obstructive pulmonary disease	0.000253	0.0111	CbGeAlD
Desipramine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000253	0.00349	CcSEcCtD
Desipramine—Petechiae—Prednisone—chronic obstructive pulmonary disease	0.000253	0.00348	CcSEcCtD
Desipramine—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00344	CcSEcCtD
Desipramine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000247	0.00341	CcSEcCtD
Desipramine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000246	0.00339	CcSEcCtD
Desipramine—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000244	0.0107	CbGeAlD
Desipramine—Benazepril—ACE—chronic obstructive pulmonary disease	0.000243	0.0774	CrCbGaD
Desipramine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000242	0.00333	CcSEcCtD
Desipramine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000238	0.00329	CcSEcCtD
Desipramine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.00327	CcSEcCtD
Desipramine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000237	0.00327	CcSEcCtD
Desipramine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000236	0.00326	CcSEcCtD
Desipramine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000236	0.00325	CcSEcCtD
Desipramine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000234	0.00323	CcSEcCtD
Desipramine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000234	0.00323	CcSEcCtD
Desipramine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00322	CcSEcCtD
Desipramine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000234	0.00322	CcSEcCtD
Desipramine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000233	0.00321	CcSEcCtD
Desipramine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00321	CcSEcCtD
Desipramine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000231	0.00319	CcSEcCtD
Desipramine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000228	0.00314	CcSEcCtD
Desipramine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00312	CcSEcCtD
Desipramine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00312	CcSEcCtD
Desipramine—HRH1—trachea—chronic obstructive pulmonary disease	0.000224	0.00985	CbGeAlD
Desipramine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000224	0.00309	CcSEcCtD
Desipramine—SLC6A2—lung—chronic obstructive pulmonary disease	0.000224	0.00983	CbGeAlD
Desipramine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00309	CcSEcCtD
Desipramine—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000223	0.0098	CbGeAlD
Desipramine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000221	0.00304	CcSEcCtD
Desipramine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000218	0.00301	CcSEcCtD
Desipramine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00298	CcSEcCtD
Desipramine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00298	CcSEcCtD
Desipramine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000215	0.00297	CcSEcCtD
Desipramine—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00295	CcSEcCtD
Desipramine—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00295	CcSEcCtD
Desipramine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00294	CcSEcCtD
Desipramine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00293	CcSEcCtD
Desipramine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00293	CcSEcCtD
Desipramine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000212	0.00292	CcSEcCtD
Desipramine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000211	0.00291	CcSEcCtD
Desipramine—Protriptyline—SLC6A4—chronic obstructive pulmonary disease	0.00021	0.0672	CrCbGaD
Desipramine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00021	0.00289	CcSEcCtD
Desipramine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00287	CcSEcCtD
Desipramine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00287	CcSEcCtD
Desipramine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000208	0.00287	CcSEcCtD
Desipramine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000206	0.00283	CcSEcCtD
Desipramine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00282	CcSEcCtD
Desipramine—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000204	0.00896	CbGeAlD
Desipramine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00281	CcSEcCtD
Desipramine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00281	CcSEcCtD
Desipramine—DRD2—lung—chronic obstructive pulmonary disease	0.000204	0.00896	CbGeAlD
Desipramine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00279	CcSEcCtD
Desipramine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00276	CcSEcCtD
Desipramine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.0002	0.00276	CcSEcCtD
Desipramine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.0002	0.00275	CcSEcCtD
Desipramine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000199	0.00275	CcSEcCtD
Desipramine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.00275	CcSEcCtD
Desipramine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000197	0.00271	CcSEcCtD
Desipramine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00271	CcSEcCtD
Desipramine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000196	0.0027	CcSEcCtD
Desipramine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.0027	CcSEcCtD
Desipramine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000196	0.0027	CcSEcCtD
Desipramine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000196	0.0027	CcSEcCtD
Desipramine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000196	0.0027	CcSEcCtD
Desipramine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.00268	CcSEcCtD
Desipramine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000194	0.00268	CcSEcCtD
Desipramine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00266	CcSEcCtD
Desipramine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00265	CcSEcCtD
Desipramine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00265	CcSEcCtD
Desipramine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00265	CcSEcCtD
Desipramine—SLC22A5—lung—chronic obstructive pulmonary disease	0.00019	0.00834	CbGeAlD
Desipramine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000189	0.0026	CcSEcCtD
Desipramine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000189	0.0026	CcSEcCtD
Desipramine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.0026	CcSEcCtD
Desipramine—HTR2A—trachea—chronic obstructive pulmonary disease	0.000187	0.00823	CbGeAlD
Desipramine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000186	0.00256	CcSEcCtD
Desipramine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00255	CcSEcCtD
Desipramine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000185	0.00255	CcSEcCtD
Desipramine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000185	0.00255	CcSEcCtD
Desipramine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00254	CcSEcCtD
Desipramine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00254	CcSEcCtD
Desipramine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00253	CcSEcCtD
Desipramine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.0025	CcSEcCtD
Desipramine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000181	0.0025	CcSEcCtD
Desipramine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000181	0.00249	CcSEcCtD
Desipramine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.00245	CcSEcCtD
Desipramine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00243	CcSEcCtD
Desipramine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00243	CcSEcCtD
Desipramine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000175	0.00242	CcSEcCtD
Desipramine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00239	CcSEcCtD
Desipramine—CYP1A2—lung—chronic obstructive pulmonary disease	0.000172	0.00756	CbGeAlD
Desipramine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00235	CcSEcCtD
Desipramine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00235	CcSEcCtD
Desipramine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00234	CcSEcCtD
Desipramine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00017	0.00234	CcSEcCtD
Desipramine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00233	CcSEcCtD
Desipramine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00231	CcSEcCtD
Desipramine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00231	CcSEcCtD
Desipramine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000167	0.0023	CcSEcCtD
Desipramine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00229	CcSEcCtD
Desipramine—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000166	0.00729	CbGeAlD
Desipramine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000166	0.00229	CcSEcCtD
Desipramine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.00229	CcSEcCtD
Desipramine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00229	CcSEcCtD
Desipramine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000165	0.00228	CcSEcCtD
Desipramine—CYP2B6—lung—chronic obstructive pulmonary disease	0.000165	0.00725	CbGeAlD
Desipramine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00226	CcSEcCtD
Desipramine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000164	0.00226	CcSEcCtD
Desipramine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.00225	CcSEcCtD
Desipramine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00224	CcSEcCtD
Desipramine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000163	0.00224	CcSEcCtD
Desipramine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.00224	CcSEcCtD
Desipramine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00222	CcSEcCtD
Desipramine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00222	CcSEcCtD
Desipramine—HRH1—lung—chronic obstructive pulmonary disease	0.000161	0.00708	CbGeAlD
Desipramine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00222	CcSEcCtD
Desipramine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.0022	CcSEcCtD
Desipramine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00219	CcSEcCtD
Desipramine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00218	CcSEcCtD
Desipramine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.00218	CcSEcCtD
Desipramine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000158	0.00217	CcSEcCtD
Desipramine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.00216	CcSEcCtD
Desipramine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.00216	CcSEcCtD
Desipramine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00216	CcSEcCtD
Desipramine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00216	CcSEcCtD
Desipramine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.00215	CcSEcCtD
Desipramine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.00215	CcSEcCtD
Desipramine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00214	CcSEcCtD
Desipramine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00214	CcSEcCtD
Desipramine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.00214	CcSEcCtD
Desipramine—CYP2E1—lung—chronic obstructive pulmonary disease	0.000155	0.0068	CbGeAlD
Desipramine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00213	CcSEcCtD
Desipramine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000154	0.00213	CcSEcCtD
Desipramine—Clomipramine—GSTP1—chronic obstructive pulmonary disease	0.000154	0.0492	CrCbGaD
Desipramine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00212	CcSEcCtD
Desipramine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.0021	CcSEcCtD
Desipramine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.00206	CcSEcCtD
Desipramine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00015	0.00206	CcSEcCtD
Desipramine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00205	CcSEcCtD
Desipramine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00205	CcSEcCtD
Desipramine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00205	CcSEcCtD
Desipramine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00205	CcSEcCtD
Desipramine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000149	0.00205	CcSEcCtD
Desipramine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00203	CcSEcCtD
Desipramine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.00203	CcSEcCtD
Desipramine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.00203	CcSEcCtD
Desipramine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000147	0.00203	CcSEcCtD
Desipramine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000147	0.00202	CcSEcCtD
Desipramine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00202	CcSEcCtD
Desipramine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000146	0.00202	CcSEcCtD
Desipramine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000146	0.00201	CcSEcCtD
Desipramine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000146	0.00201	CcSEcCtD
Desipramine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00195	CcSEcCtD
Desipramine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00194	CcSEcCtD
Desipramine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00194	CcSEcCtD
Desipramine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000139	0.00191	CcSEcCtD
Desipramine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00186	CcSEcCtD
Desipramine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00186	CcSEcCtD
Desipramine—HTR2A—lung—chronic obstructive pulmonary disease	0.000135	0.00591	CbGeAlD
Desipramine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000133	0.00184	CcSEcCtD
Desipramine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.00184	CcSEcCtD
Desipramine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000133	0.00183	CcSEcCtD
Desipramine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000131	0.0018	CcSEcCtD
Desipramine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00178	CcSEcCtD
Desipramine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00178	CcSEcCtD
Desipramine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.00177	CcSEcCtD
Desipramine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00176	CcSEcCtD
Desipramine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00174	CcSEcCtD
Desipramine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00174	CcSEcCtD
Desipramine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00172	CcSEcCtD
Desipramine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00172	CcSEcCtD
Desipramine—ABCB1—trachea—chronic obstructive pulmonary disease	0.000123	0.00539	CbGeAlD
Desipramine—Maprotiline—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.039	CrCbGaD
Desipramine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000122	0.00168	CcSEcCtD
Desipramine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00168	CcSEcCtD
Desipramine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00166	CcSEcCtD
Desipramine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00012	0.00165	CcSEcCtD
Desipramine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.00165	CcSEcCtD
Desipramine—Epinastine—HTR2A—chronic obstructive pulmonary disease	0.00012	0.0383	CrCbGaD
Desipramine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.00164	CcSEcCtD
Desipramine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000119	0.00164	CcSEcCtD
Desipramine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000119	0.00164	CcSEcCtD
Desipramine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.00164	CcSEcCtD
Desipramine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00164	CcSEcCtD
Desipramine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000118	0.00163	CcSEcCtD
Desipramine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.00163	CcSEcCtD
Desipramine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.00163	CcSEcCtD
Desipramine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.00162	CcSEcCtD
Desipramine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000117	0.00162	CcSEcCtD
Desipramine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000116	0.0016	CcSEcCtD
Desipramine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000116	0.0016	CcSEcCtD
Desipramine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.0016	CcSEcCtD
Desipramine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000116	0.0016	CcSEcCtD
Desipramine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000116	0.00159	CcSEcCtD
Desipramine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00158	CcSEcCtD
Desipramine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00157	CcSEcCtD
Desipramine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00157	CcSEcCtD
Desipramine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.00156	CcSEcCtD
Desipramine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.00156	CcSEcCtD
Desipramine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.00155	CcSEcCtD
Desipramine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.00155	CcSEcCtD
Desipramine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000112	0.00154	CcSEcCtD
Desipramine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.00154	CcSEcCtD
Desipramine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.00154	CcSEcCtD
Desipramine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00011	0.00151	CcSEcCtD
Desipramine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.00149	CcSEcCtD
Desipramine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.00149	CcSEcCtD
Desipramine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.00146	CcSEcCtD
Desipramine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00145	CcSEcCtD
Desipramine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000104	0.00143	CcSEcCtD
Desipramine—Maprotiline—HTR2A—chronic obstructive pulmonary disease	0.000103	0.0329	CrCbGaD
Desipramine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.00141	CcSEcCtD
Desipramine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	9.97e-05	0.00137	CcSEcCtD
Desipramine—Flushing—Prednisone—chronic obstructive pulmonary disease	9.69e-05	0.00134	CcSEcCtD
Desipramine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	9.33e-05	0.00129	CcSEcCtD
Desipramine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.24e-05	0.00127	CcSEcCtD
Desipramine—Atomoxetine—SLC6A4—chronic obstructive pulmonary disease	9.23e-05	0.0295	CrCbGaD
Desipramine—Alopecia—Prednisone—chronic obstructive pulmonary disease	9.23e-05	0.00127	CcSEcCtD
Desipramine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.17e-05	0.00126	CcSEcCtD
Desipramine—Mianserin—SLC6A4—chronic obstructive pulmonary disease	9.02e-05	0.0288	CrCbGaD
Desipramine—Carbamazepine—CYP1A2—chronic obstructive pulmonary disease	8.92e-05	0.0285	CrCbGaD
Desipramine—ABCB1—lung—chronic obstructive pulmonary disease	8.82e-05	0.00387	CbGeAlD
Desipramine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	8.57e-05	0.00118	CcSEcCtD
Desipramine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.44e-05	0.00116	CcSEcCtD
Desipramine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.41e-05	0.00116	CcSEcCtD
Desipramine—Agitation—Prednisone—chronic obstructive pulmonary disease	8.35e-05	0.00115	CcSEcCtD
Desipramine—Acepromazine—HTR2A—chronic obstructive pulmonary disease	8.34e-05	0.0266	CrCbGaD
Desipramine—Clomipramine—SLC6A4—chronic obstructive pulmonary disease	8.25e-05	0.0263	CrCbGaD
Desipramine—Mianserin—CYP1A2—chronic obstructive pulmonary disease	8.22e-05	0.0262	CrCbGaD
Desipramine—Malaise—Prednisone—chronic obstructive pulmonary disease	8.2e-05	0.00113	CcSEcCtD
Desipramine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	8.11e-05	0.00112	CcSEcCtD
Desipramine—Nortriptyline—SLC6A4—chronic obstructive pulmonary disease	8.06e-05	0.0257	CrCbGaD
Desipramine—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.88e-05	0.00109	CcSEcCtD
Desipramine—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.85e-05	0.00108	CcSEcCtD
Desipramine—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.71e-05	0.00106	CcSEcCtD
Desipramine—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.65e-05	0.00105	CcSEcCtD
Desipramine—Trimipramine—SLC6A4—chronic obstructive pulmonary disease	7.59e-05	0.0242	CrCbGaD
Desipramine—Oxcarbazepine—ALB—chronic obstructive pulmonary disease	7.56e-05	0.0241	CrCbGaD
Desipramine—Clomipramine—CYP1A2—chronic obstructive pulmonary disease	7.51e-05	0.024	CrCbGaD
Desipramine—Oedema—Prednisone—chronic obstructive pulmonary disease	7.42e-05	0.00102	CcSEcCtD
Desipramine—Nortriptyline—CYP1A2—chronic obstructive pulmonary disease	7.34e-05	0.0234	CrCbGaD
Desipramine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.000998	CcSEcCtD
Desipramine—Doxepin—SLC6A4—chronic obstructive pulmonary disease	7.24e-05	0.0231	CrCbGaD
Desipramine—Atomoxetine—HTR2A—chronic obstructive pulmonary disease	7.09e-05	0.0226	CrCbGaD
Desipramine—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.07e-05	0.000975	CcSEcCtD
Desipramine—Mianserin—HTR2A—chronic obstructive pulmonary disease	6.93e-05	0.0221	CrCbGaD
Desipramine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.75e-05	0.000931	CcSEcCtD
Desipramine—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.71e-05	0.000925	CcSEcCtD
Desipramine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.66e-05	0.000918	CcSEcCtD
Desipramine—Doxepin—CYP1A2—chronic obstructive pulmonary disease	6.59e-05	0.021	CrCbGaD
Desipramine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.53e-05	0.0009	CcSEcCtD
Desipramine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.45e-05	0.000889	CcSEcCtD
Desipramine—Rash—Prednisolone—chronic obstructive pulmonary disease	6.44e-05	0.000887	CcSEcCtD
Desipramine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.43e-05	0.000887	CcSEcCtD
Desipramine—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.4e-05	0.000882	CcSEcCtD
Desipramine—Headache—Prednisolone—chronic obstructive pulmonary disease	6.4e-05	0.000882	CcSEcCtD
Desipramine—Constipation—Prednisone—chronic obstructive pulmonary disease	6.35e-05	0.000875	CcSEcCtD
Desipramine—Clomipramine—HTR2A—chronic obstructive pulmonary disease	6.34e-05	0.0202	CrCbGaD
Desipramine—Nortriptyline—HTR2A—chronic obstructive pulmonary disease	6.2e-05	0.0198	CrCbGaD
Desipramine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.11e-05	0.000843	CcSEcCtD
Desipramine—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.07e-05	0.000836	CcSEcCtD
Desipramine—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.89e-05	0.000812	CcSEcCtD
Desipramine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.87e-05	0.000808	CcSEcCtD
Desipramine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.87e-05	0.000808	CcSEcCtD
Desipramine—Promazine—CYP1A2—chronic obstructive pulmonary disease	5.86e-05	0.0187	CrCbGaD
Desipramine—Trimipramine—HTR2A—chronic obstructive pulmonary disease	5.84e-05	0.0186	CrCbGaD
Desipramine—Acepromazine—ALB—chronic obstructive pulmonary disease	5.71e-05	0.0182	CrCbGaD
Desipramine—Imipramine—SLC6A4—chronic obstructive pulmonary disease	5.63e-05	0.018	CrCbGaD
Desipramine—Promethazine—HTR2A—chronic obstructive pulmonary disease	5.62e-05	0.0179	CrCbGaD
Desipramine—Amitriptyline—SLC6A4—chronic obstructive pulmonary disease	5.6e-05	0.0179	CrCbGaD
Desipramine—Doxepin—HTR2A—chronic obstructive pulmonary disease	5.56e-05	0.0178	CrCbGaD
Desipramine—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.32e-05	0.000734	CcSEcCtD
Desipramine—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.25e-05	0.000724	CcSEcCtD
Desipramine—Chlorpromazine—CYP1A2—chronic obstructive pulmonary disease	5.15e-05	0.0165	CrCbGaD
Desipramine—Imipramine—CYP1A2—chronic obstructive pulmonary disease	5.13e-05	0.0164	CrCbGaD
Desipramine—Amitriptyline—CYP1A2—chronic obstructive pulmonary disease	5.1e-05	0.0163	CrCbGaD
Desipramine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.08e-05	0.0007	CcSEcCtD
Desipramine—Promazine—HTR2A—chronic obstructive pulmonary disease	4.94e-05	0.0158	CrCbGaD
Desipramine—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.91e-05	0.000676	CcSEcCtD
Desipramine—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.72e-05	0.00065	CcSEcCtD
Desipramine—Rash—Prednisone—chronic obstructive pulmonary disease	4.68e-05	0.000645	CcSEcCtD
Desipramine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.67e-05	0.000644	CcSEcCtD
Desipramine—Headache—Prednisone—chronic obstructive pulmonary disease	4.65e-05	0.000641	CcSEcCtD
Desipramine—Nausea—Prednisone—chronic obstructive pulmonary disease	4.41e-05	0.000607	CcSEcCtD
Desipramine—Chlorpromazine—HTR2A—chronic obstructive pulmonary disease	4.35e-05	0.0139	CrCbGaD
Desipramine—Clomipramine—ALB—chronic obstructive pulmonary disease	4.34e-05	0.0139	CrCbGaD
Desipramine—Imipramine—HTR2A—chronic obstructive pulmonary disease	4.33e-05	0.0138	CrCbGaD
Desipramine—Amitriptyline—HTR2A—chronic obstructive pulmonary disease	4.3e-05	0.0137	CrCbGaD
Desipramine—Nortriptyline—ALB—chronic obstructive pulmonary disease	4.24e-05	0.0135	CrCbGaD
Desipramine—Chlorpromazine—ALB—chronic obstructive pulmonary disease	2.98e-05	0.0095	CrCbGaD
Desipramine—Amitriptyline—ALB—chronic obstructive pulmonary disease	2.94e-05	0.00939	CrCbGaD
Desipramine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.8e-06	0.000102	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.8e-06	0.000102	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.79e-06	0.000102	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.79e-06	0.000102	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	4.75e-06	0.000101	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.73e-06	0.000101	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.72e-06	0.000101	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	4.71e-06	0.0001	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.69e-06	0.0001	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.69e-06	0.0001	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.62e-06	9.87e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.62e-06	9.86e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.62e-06	9.85e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.6e-06	9.81e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.6e-06	9.8e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.59e-06	9.79e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.57e-06	9.74e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.52e-06	9.64e-05	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.47e-06	9.53e-05	CbGpPWpGaD
Desipramine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.46e-06	9.52e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.43e-06	9.46e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.42e-06	9.43e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.4e-06	9.39e-05	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.4e-06	9.38e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.4e-06	9.38e-05	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.39e-06	9.36e-05	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.37e-06	9.33e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.36e-06	9.31e-05	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.36e-06	9.3e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.35e-06	9.29e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.34e-06	9.26e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.34e-06	9.25e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	4.33e-06	9.24e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.33e-06	9.23e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.32e-06	9.21e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.31e-06	9.19e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.3e-06	9.18e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.29e-06	9.16e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.28e-06	9.14e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.23e-06	9.03e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.2e-06	8.96e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.17e-06	8.9e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.12e-06	8.79e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.11e-06	8.76e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.11e-06	8.76e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.09e-06	8.72e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.09e-06	8.71e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.07e-06	8.68e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.06e-06	8.65e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.03e-06	8.6e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.02e-06	8.58e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.99e-06	8.52e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.99e-06	8.51e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.98e-06	8.5e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.97e-06	8.47e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.97e-06	8.46e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.96e-06	8.44e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.96e-06	8.44e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.94e-06	8.41e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.93e-06	8.39e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.93e-06	8.39e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.92e-06	8.37e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.92e-06	8.36e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.89e-06	8.31e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.88e-06	8.28e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.83e-06	8.17e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.81e-06	8.13e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.8e-06	8.1e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.78e-06	8.07e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.76e-06	8.01e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.75e-06	8e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.75e-06	7.99e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.67e-06	7.83e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.66e-06	7.81e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.62e-06	7.72e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.61e-06	7.69e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.57e-06	7.61e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	3.57e-06	7.61e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.55e-06	7.57e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.54e-06	7.55e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.53e-06	7.53e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.53e-06	7.53e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.53e-06	7.53e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.52e-06	7.51e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	3.51e-06	7.5e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.48e-06	7.43e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.48e-06	7.43e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.48e-06	7.42e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.45e-06	7.37e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.41e-06	7.28e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.38e-06	7.2e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.37e-06	7.19e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.36e-06	7.17e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.36e-06	7.17e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.33e-06	7.11e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.33e-06	7.1e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.32e-06	7.09e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.31e-06	7.06e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.3e-06	7.03e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	3.3e-06	7.03e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.28e-06	7e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.25e-06	6.92e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.22e-06	6.88e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.22e-06	6.86e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.21e-06	6.84e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.17e-06	6.76e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	3.15e-06	6.72e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.15e-06	6.72e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.15e-06	6.71e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.15e-06	6.71e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.14e-06	6.7e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.1e-06	6.62e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.08e-06	6.56e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.08e-06	6.56e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.06e-06	6.53e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.06e-06	6.52e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.01e-06	6.43e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.97e-06	6.33e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.92e-06	6.22e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.91e-06	6.21e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.9e-06	6.19e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.9e-06	6.18e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.89e-06	6.17e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.86e-06	6.11e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.85e-06	6.09e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	2.84e-06	6.05e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.83e-06	6.04e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.83e-06	6.04e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.83e-06	6.03e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.82e-06	6.01e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.79e-06	5.96e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.78e-06	5.94e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.78e-06	5.93e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.78e-06	5.93e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	2.78e-06	5.92e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.77e-06	5.91e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.76e-06	5.89e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.73e-06	5.83e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.73e-06	5.82e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.72e-06	5.79e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.71e-06	5.79e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.71e-06	5.79e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.71e-06	5.77e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.7e-06	5.76e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.66e-06	5.67e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.66e-06	5.67e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.65e-06	5.66e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.65e-06	5.66e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.64e-06	5.64e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.64e-06	5.62e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.61e-06	5.57e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.61e-06	5.56e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.6e-06	5.54e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.59e-06	5.53e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.59e-06	5.53e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.58e-06	5.51e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.58e-06	5.51e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.54e-06	5.42e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.53e-06	5.39e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.48e-06	5.3e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.47e-06	5.27e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.46e-06	5.24e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.46e-06	5.24e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.43e-06	5.19e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.4e-06	5.11e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.36e-06	5.03e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.35e-06	5.02e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.35e-06	5e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.34e-06	4.99e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.32e-06	4.94e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.32e-06	4.94e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.28e-06	4.86e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.27e-06	4.84e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.24e-06	4.78e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.24e-06	4.77e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.23e-06	4.76e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.22e-06	4.74e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.22e-06	4.73e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.21e-06	4.71e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.2e-06	4.7e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.18e-06	4.64e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.17e-06	4.62e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.15e-06	4.58e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	2.14e-06	4.57e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.13e-06	4.55e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.13e-06	4.55e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.13e-06	4.54e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.13e-06	4.54e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.12e-06	4.53e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.11e-06	4.51e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.09e-06	4.47e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2.09e-06	4.46e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.09e-06	4.45e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.08e-06	4.44e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	2.05e-06	4.37e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.04e-06	4.36e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.04e-06	4.35e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.03e-06	4.34e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.02e-06	4.32e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2e-06	4.27e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2e-06	4.26e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2e-06	4.26e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.98e-06	4.23e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.97e-06	4.2e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.95e-06	4.17e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.95e-06	4.15e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.92e-06	4.09e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.91e-06	4.08e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.91e-06	4.06e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.9e-06	4.05e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.9e-06	4.04e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.88e-06	4.02e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.88e-06	4.01e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.87e-06	3.99e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.79e-06	3.81e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.76e-06	3.75e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.75e-06	3.74e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.75e-06	3.74e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.75e-06	3.74e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.75e-06	3.73e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.74e-06	3.72e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.73e-06	3.68e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.72e-06	3.68e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.72e-06	3.67e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.71e-06	3.66e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.71e-06	3.65e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.71e-06	3.65e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.69e-06	3.61e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.68e-06	3.57e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.67e-06	3.56e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.67e-06	3.56e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.6e-06	3.42e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.6e-06	3.41e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.57e-06	3.35e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.53e-06	3.27e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.53e-06	3.25e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.47e-06	3.14e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.45e-06	3.09e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.44e-06	3.08e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.44e-06	3.07e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.43e-06	3.06e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.42e-06	3.03e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.35e-06	2.87e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.32e-06	2.83e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.32e-06	2.82e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.32e-06	2.81e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.31e-06	2.8e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.3e-06	2.77e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.29e-06	2.75e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.23e-06	2.63e-05	CbGpPWpGaD
